NMOSD was considered as a severe variant of MS, and various types of immune cells [including regulatory T cells (34), neutrophils (35), and B lymphocytes (36)] and cytokines [including IL-6 (37), IFN (38), and IL-10 (34)] are involved in disease onset and progression. Here, IL6 is linked to myeloid sarcoma.